A pregnant 18-year-old female patient presented with cerebral lupus and was admitted to the hospital with fever and inability to speak or stand. She was diagnosed with cerebral lupus based on meeting ARA criteria and exhibiting neuropsychiatric symptoms of SLE. Her pregnancy was considered high-risk due to a severe lupus flare and low amniotic fluid index, but termination was refused by her family. She was treated with corticosteroids and cyclophosphamide, showing improvement in her cerebral lupus symptoms.
Neonatal lupus (NL) is a disease of the newborn which can be detected early in pregnancy and is linked to Anti-Ro &
Anti-La antibodies. The most dreaded complication of this disease is the presence of 2nd or 3rd degree heart block,
sometimes leading to Complete Heart Block (CHB). Other manifestations like skin rashes, transient elevations of
transaminases and cytopenias (hematological) are of no serious consequence and can be treated symptomatically.
The management of NL is primarily a preventive strategy and involves close cardiac monitoring of the fetus during the 18th-32nd week of pregnancy.
Hello readers.................!!!!!!!!!!!!!!
This is my 32nd powerpoint.....its regarding a form of childhood epilepsy, known as "LENNOX-GASTAUT SYNDROME".
It has been dealt with in the Therapeutics way, and in precise format.
Do look into it and give your reviews!!!!
Thank you!!!!
@rxvichu-alwz4uh!!!!
:) :)
Neonatal lupus (NL) is a disease of the newborn which can be detected early in pregnancy and is linked to Anti-Ro &
Anti-La antibodies. The most dreaded complication of this disease is the presence of 2nd or 3rd degree heart block,
sometimes leading to Complete Heart Block (CHB). Other manifestations like skin rashes, transient elevations of
transaminases and cytopenias (hematological) are of no serious consequence and can be treated symptomatically.
The management of NL is primarily a preventive strategy and involves close cardiac monitoring of the fetus during the 18th-32nd week of pregnancy.
Hello readers.................!!!!!!!!!!!!!!
This is my 32nd powerpoint.....its regarding a form of childhood epilepsy, known as "LENNOX-GASTAUT SYNDROME".
It has been dealt with in the Therapeutics way, and in precise format.
Do look into it and give your reviews!!!!
Thank you!!!!
@rxvichu-alwz4uh!!!!
:) :)
Intra Cranial Stem Cell Transplant For Npc.Ppt 2Duriya Lakdawala
Finding a treatment for Niemann Pick Type C will provide hope not only to Aaditya Ravi Dasgupta and Tasneem Tankiwala in India but to many others like Addi and Cassi Hempel, Gabrielle Laverde and Peyton and Kayla Hadley in US, Husein Taher in Tanzania, South Africa, Roy Green in UK and so many more kids, teens and adults all over the world and in India that have not been diagnosed yet due to the cost and complexity of the diagnostic process. You can leave a wish for Aaditya (http://addiandcassi.com/guestbook) or for more information go to: www.HopeforAaditya.org
Michael J. Kavanaugh, M.D., of U.S. Navy Medicine, presents "An Unusual Presentation of a Known HIV Related Condition Presenting as a Septic Mimic" at AIDS Clinical Rounds
Systemic lupus erythematosus (SLE) is an autoimmune disease. In this disease, the immune system of the body mistakenly attacks healthy tissue. It can affect the skin, joints, kidneys, brain, and other organs.
Intra Cranial Stem Cell Transplant For Npc.Ppt 2Duriya Lakdawala
Finding a treatment for Niemann Pick Type C will provide hope not only to Aaditya Ravi Dasgupta and Tasneem Tankiwala in India but to many others like Addi and Cassi Hempel, Gabrielle Laverde and Peyton and Kayla Hadley in US, Husein Taher in Tanzania, South Africa, Roy Green in UK and so many more kids, teens and adults all over the world and in India that have not been diagnosed yet due to the cost and complexity of the diagnostic process. You can leave a wish for Aaditya (http://addiandcassi.com/guestbook) or for more information go to: www.HopeforAaditya.org
Michael J. Kavanaugh, M.D., of U.S. Navy Medicine, presents "An Unusual Presentation of a Known HIV Related Condition Presenting as a Septic Mimic" at AIDS Clinical Rounds
Systemic lupus erythematosus (SLE) is an autoimmune disease. In this disease, the immune system of the body mistakenly attacks healthy tissue. It can affect the skin, joints, kidneys, brain, and other organs.
A case of Neuromyelitis optica as a presenting manifestation of Systemic Lupu...Apollo Hospitals
Neuromyelitis optica (NMO) is a well characterised, autoimmune, clinicopathological syndrome, which is uncommon and occurs as an isolated entity. Unlike multiple sclerosis, in NMO, the autoimmunity is humorally mediated and the recent availability of Antiaquaporin antibody testing has increased the positive diagnosis of this condition. NMO can also occur in patients with established Systemic Lupus Erythematosis (SLE) who have multiple autoantibodies. The presence of Antiaquaporin antibody is specific for NMO and is seen in patients with SLE who develop inflammatory CNS disease. However, Neuromyelitis optica occurring as a presenting manifestation of SLE is extremely rare and we report one such case.
This presentation discusses the various presentation of inborn error of metabolism to pediatric ICU and basic management of such cases. Also discusses the basic evaluation and iagnostic appraoch to various inborn of error of metabolism with consideration to pediatric critical care
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
A Pregnant Patient With Cerebral Lupus
1. A PREGNANT PATIENT WITH CEREBRAL LUPUS Puguh Widagdo Joewono Soeroso , CASE PRESENTATION Department of Internal Medicine Dr Soetomo Teaching Hospital- Airlangga University School of Medicine SURABAYA
2.
3.
4.
5. Mrs N, 18 y.o married, Javanese, moslem, stay at Surabaya Admitted to dr.Soetomo hospital on Jan 21 th 2009 Chief complaint : FEVER PATIENT IDENTITY CASE
6. History of Present Ilness High fever since 5 days before admission, shiver (-), not getting better with fever lowering agent . Suddendly 1 day before admission, the patient became silent couldn’t speak and stand. Patient was in 3 months of the 2 nd pregnancy Body & hinge pain (+), headac h e (+), oral ulcer (+), hair loss (+), facial rash (+), photosensitive (+) History of Past Ilness Family History History of diabetes mellitus, hypertension and abortus was not found 1 st pregnancy : normal delivery No family with the same disease
7.
8. , Laboratory Examination Hb 11,2 g/dl ; WBC 14000/l ; PLT 124.000 u/l ; HCT 35,3 %; RBS 104 mg/dl; BUN 31 mg/dl; Cr 1.7 mg/dl; SGOT 30 u/l; SGPT 24 u/l Total prot. 5.5 g/dl; Albumin 2.9 g/dl ; Total bil 0.8 mg/dl; direct bil 0.2 mg/dl; Potassium 2,67 mmol/l; Sodium 136,7 mmol/l. Blood gas analysis (BGA): pH 7,38; pCO2 20 mmHg; pO2 107 mmHg; HCO3 11,8mmol/l; BE -13mmol; SO2 98 % Jan 21 th ,2009
9. Radiologic Imaging Conclusion : No abnormality Jan 21 th ,2009 Chest x-ray Conclusion : No abnormality Ct – Scan Skull Conclusion : No abnormality Feb 5 th ,2009 Obstetry USG Conclusion : BP 38, FL 21, amnion fluid ( - ) Feb 10 th ,2009
10. Initial Assesment Cerebral lupus + S.Sepsis (unknown source of infection ) + G 2 P 1-1 + Hypokalemia Planning : Urinalysis and urine sediment, ANA test, CRP, C3, C4 Blood and urine culture DX: TX: O2 4 lpm Bed rest Enteral diet HCHP 6x150 cc RL : D 5 infusion :2:2 Ceftriaxone injection 2x1g Paracetamol 3x 500mg Hypokelemia correction with KCL 50mg in RL 500 cc / 24 hour
11.
12. Jan 22 nd ,2009 (day 2) S: Agitation scream, delirium (GCS 4x6), weak . ESR 50 mm/hour SGOT 45 u/l, SGPT 42 u/l, BUN 30 mg/dl, Cr 1,7 mg/dl, Na 136,7 mmol/ L K 2,35 mmol/L O: T 120/80, HR 96 bpm RR 25 x/m , t 37,8 ºC A: Cerebral lupus + suspected sepsis (un known source of infection ) + G 2 P 1-1 + Hypokalemia P: Bedrest Enteral diet 6x150 cc Rl : D 5 infusion 2:2 Ceftriaxone injection 2x1 g Pulse dose Methylprednisolon 500 mg/u in 100 cc PZ in 3 day Neurolog y : decline of awareness without e ither meningeal sign or focal neurologic deficit due to metabolic encephalopathy , Unspesific seizure possibly due to hypokalemia Adv : EEG if transportable Psychia tric : mental organic disorder due to SLE Adv : treat organic cause and Haloperidol 2 x 0,5 mg or Haloperidol injection (1/2 ampul i.v) if agitated
13. Jan 25 th ,2009 (day 5) Agitation Scream, Weak GCS 224, ANA Test moderate (+) (45 UNIT) BUN 29 mg/dl Cr 0,73 mg/dl, K 2,9 mmol/l, C3 3 mg/dl, C 4 13 mg/dl Blood Culture : Staphylococcus coagulase negative, sensitive with sefoperazone-sulbactam Dx : CEREBRAL LUPUS + SEPSIS + G2P1-1 + HYPOKALEMIA Tx : ~ 2nd day, Methylprednisolon 60 mg iv, Sefoperazone – Sulbactam Injection 3x1g Blood culture : Corynebacterium spp (+), sensitive with Ceftazidime Tx :~ 5th day, Ceftazidime inj 3x1g SKULL CT-SCAN WITHOUT CONTRAST : NO ABNORMALITY ABDOMINAL USG : AMNIOTIC FLUID (-) TX : ~ 15TH DAY, CYCLOFOSFAMIDE DRIP 500 mg IN 500CC PZ IN 5 HOUR ( INFORMED CON S ENT ) Feb 5 th ,2009 (day 15) Feb 10 th ,2009 (day 20) Feb 1 th ,2009 (day 12)
14. Conference with Obgyn Dept : Considering severe flare of SLE ( cerebral lupus ) which is unresponsive with the treatment and amniotic fluid index (-). The pregnancy should be terminated . T he family refuse it. Patient could eat and drink minimally , GCS 456 Patient could eat and drink minimally, minimal daily activity GCS 4-5-6 Discharge from hospital terapy : Methylprednisolon 8mg-0-0 Chloroquinolon 1 x 100 mg Ca2 vit D31x1 Feb 15 th ,2009 (day 25) Mar 2 th ,2009 (day 35) Feb 25 th ,2009 (day 30)
16. TISSUE NECROSIS Autoreactive T cell TH cell B cell Auto Ag Auto Ab Complement Activation Platelet Agregation Hagemen factor activation VAS C ULITIS TROMBUS NEUROENDOCRINE (SEX HORMONE) GENETIC PATOGENESIS ENVIRONMENT (U V, INFECTION ) IMMUNE COMPLEX
17.
18. Diagnosis American Rheumatism Association (ARA ) criteria REF CASE REF CASE Malar rash (+) Renal disorder (-) Discoid rash (-) Neurologic disorder (+) Photosensitivity (+) Hematologic disorder (-) Oral ulcer (+) Immunologic disorder Anti ds DNA Anti SM Not Examined Arthritis (+) Serositis (-) Antinuclear antibody ANA - test (+)
19. , Bleeding D y sfunctional Plexus coroides Anti neural Antibody Mechanism of cerebral lupus Neuroendocrine Immune System CNS Injury Vascular Oclusion CEREBRAL LUPUS
20.
21. , DIAGNOSIS OF CEREBRAL LUPUS ARA Criteria Neuropsychiatric sign Laboratory test, neuropsyc h ology test, imaging = non SLE